McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. authors DDN News article dated January 2020 entitled, “The Federal Circuit continues to expand the scope of patent-ineligible invention in its recent iNo Therapeutics LLC v. Praxair Distribution Inc. decision, relying on Justice Breyer’s exhortation, in his Mayo Collaborative Serv. Inc. v. Prometheus Laboratories opinion, about the need to beware of “interpreting patent statutes in ways that make patent eligibility ‘depend simply on the draftsman’s art’ without reference to the ‘principles underlying the prohibition against patents for [natural laws].” view the article
